• Home
    • COVID-19 Policy
    • Contact Us
    • About Us
    • Newsletters
  • November Participation
  • Clinical Trials
    • Enrolling
    • Completed
  • "One & Done"
  • Research Sponsors
  • Shareholders
ANTRIA INC
  • Home
    • COVID-19 Policy
    • Contact Us
    • About Us
    • Newsletters
  • November Participation
  • Clinical Trials
    • Enrolling
    • Completed
  • "One & Done"
  • Research Sponsors
  • Shareholders
NCT00745290
A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty
Phase III: Postoperative Pain

NCT02713178
Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty
Phase III: Pain

NCT02713230
Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery
Phase III: Pain

NCT02807428
Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery
Phase II: Post-surgical Pain

NCT02683239
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
Phase III: Osteoarthritis of the Knee or Hip

NCT03070951
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Phase III: Uterine Fibroids, Heavy Menstrual Bleeding

NCT03492281
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)
Phase III: Overactive Bladder

NCT03583372
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) for up to 52 Weeks.
Phase III: Overactive Bladder

NCT03451916
Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)
Phase III: Hip Fracture

NCT03297398
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Phase II: Benign Prostatic Hyperplasia

NCT03487913
A Study of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Phase II: Autosomal Dominant Polycystic Kidney Disease

NCT03354598
Oral Sulopenem Etzadroxil With Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women
Phase III: Urinary Tract Infections, Antibiotic Resistant Infection

NCT02267382
A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Phase II: Recurrent Vulvovaginal Candidiasis

NCT03897374
Strategic Targeting for Optimal Prevention of Cancer
Early Detection of Cancer
Observational [Patient Registry]

NCT03905863
The Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers
Diabetic Foot Ulcer, Surgical Wound

NCT03797612
Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Knee Replacement in Patients With High PCS Scores
Phase II: Pain, Postoperative
​
NCT03719300
Study of BC-819 in NMIBC Patients Unresponsive to BCG
Phase II: Non-muscle Invasive Bladder Cancer (NMIBC)
Proudly powered by Weebly
  • Home
    • COVID-19 Policy
    • Contact Us
    • About Us
    • Newsletters
  • November Participation
  • Clinical Trials
    • Enrolling
    • Completed
  • "One & Done"
  • Research Sponsors
  • Shareholders